Investor Alert

New York Markets After Hours

Syros Pharmaceuticals Inc.



After Hours

 --Real time quotes

Sep 27, 2022, 4:29 p.m.





0.00 0.00%


Volume 321

Real time quotes


Today's close

$ 5.58

$ 5.34


-0.24 -4.30%

Day low

Day high




52 week low

52 week high




Annual Financials for Syros Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Cash & Short Term Investments 72.24M100.32M91.71M173.98M130.37M
Cash Only 32.4M50.52M41.73M173.98M92.3M
Short-Term Investments -----
Total Accounts Receivable --20.16M2.33M2.98M
Accounts Receivables, Net --20.16M2.33M2.98M
Accounts Receivables, Gross 0-20.16M2.33M2.98M
Bad Debt/Doubtful Accounts -----
Other Receivables -----
Inventories -----
Finished Goods -----
Work in Progress -----
Raw Materials -----
Progress Payments & Other -----
Other Current Assets 917,0001.42M2.65M2.24M3.24M
Miscellaneous Current Assets 917,0001.42M2.65M2.24M3.24M
Total Current Assets 73.16M101.73M114.51M178.56M136.59M
20172018201920202021 5-year trend
Net Property, Plant & Equipment 3.94M3.86M31.89M29.64M27.29M
Property, Plant & Equipment - Gross 7.64M9.16M36.33M36.86M37.14M
Buildings -----
Land & Improvements -----
Computer Software and Equipment 651,0001.08M1.63M1.84M1.98M
Other Property, Plant & Equipment 3.01M3.16M12.46M12.55M12.73M
Accumulated Depreciation 3.7M5.3M4.44M7.22M-
Total Investments and Advances 290,000290,0003.09M3.09M16.12M
Other Long-Term Investments 290,000290,0003.09M3.09M16.12M
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 1.1M881,000490,0001.97M2.94M
Tangible Other Assets 1.1M881,000490,0001.97M2.94M
Total Assets 78.49M106.77M149.98M213.25M182.94M

Liabilities & Shareholders' Equity

20172018201920202021 5-year trend
ST Debt & Current Portion LT Debt 47,0009,0001.28M1.73M2.01M
Short Term Debt --1.04M1.46M-
Current Portion of Long Term Debt 47,0009,000241,000265,000291,000
Accounts Payable 2.28M3.31M5.85M3.6M3.69M
Income Tax Payable -----
Other Current Liabilities 10.08M16.21M16.39M23.29M25.81M
Dividends Payable -----
Accrued Payroll 2.49M2.99M4.17M5.72M6.34M
Miscellaneous Current Liabilities 7.59M13.23M12.21M17.58M19.46M
Total Current Liabilities 12.41M19.53M23.52M28.62M31.51M
Long-Term Debt 6,00022,00024.64M64.49M63.18M
Long-Term Debt excl. Capitalized Leases ---39.55M40.26M
Non-Convertible Debt ---39.55M40.26M
Convertible Debt -----
Capitalized Lease Obligations 6,00022,000621,000356,00065,000
Provision for Risks & Charges -----
Deferred Taxes -----
Deferred Taxes - Credit -----
Deferred Taxes - Debit -----
Other Liabilities 745,0008.63M22.64M29.59M3.03M
Other Liabilities (excl. Deferred Income) 745,000353,000-19.71M3.03M
Deferred Income -8.28M22.64M9.88M-
Total Liabilities 13.16M28.18M70.79M122.7M97.72M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 65.32M78.59M79.18M90.55M85.22M
Common Stock Par/Carry Value 26,00034,00043,00056,00061,000
Retained Earnings (155.27M)(217.55M)(292.98M)(377.02M)(463.58M)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities (42,000)(3,000)24,000-(79,000)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 65.32M78.59M79.18M90.55M85.22M
Accumulated Minority Interest -----
Total Equity 65.32M78.59M79.18M90.55M85.22M
Liabilities & Shareholders' Equity 78.49M106.77M149.98M213.25M182.94M
Link to MarketWatch's Slice.